We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.19B
AUM Growth
+$184M
Cap. Flow
+$103M
Cap. Flow %
8.71%
Top 10 Hldgs %
36.02%
Holding
360
New
23
Increased
72
Reduced
151
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Consumer Discretionary 9.03%
3 Financials 8.98%
4 Healthcare 8.93%
5 Industrials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLQD icon
126
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.37B
$817K 0.07%
17,073
-19,887
-54% -$947K
ENB icon
127
Enbridge
ENB
$119B
$811K 0.07%
20,743
+650
+3% +$25.4K
FPE icon
128
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$810K 0.07%
+48,200
New +$809K
RTX icon
129
RTX Corp
RTX
$290B
$762K 0.06%
7,547
+768
+11% +$72.2K
GEN icon
130
Gen Digital
GEN
$16.4B
$757K 0.06%
35,328
-3,150
-8% -$69.6K
VWO icon
131
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$750K 0.06%
19,246
+2,007
+12% +$76.5K
SENEA icon
132
Seneca Foods Class A
SENEA
$1.12B
$750K 0.06%
12,300
-2,900
-19% -$178K
BMY icon
133
Bristol-Myers Squibb
BMY
$133B
$728K 0.06%
10,116
+552
+6% +$41.6K
GWW icon
134
W.W. Grainger
GWW
$65.3B
$723K 0.06%
1,300
GDO
135
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.1M
$719K 0.06%
56,300
-11,000
-16% -$134K
ELV icon
136
Elevance Health
ELV
$81.5B
$718K 0.06%
1,400
-12
-0.8% -$6.09K
RNP icon
137
Cohen & Steers REIT and Preferred and Income Fund
RNP
$982M
$717K 0.06%
35,200
-2,200
-6% -$46.8K
MA icon
138
Mastercard
MA
$502B
$713K 0.06%
2,050
-33
-2% -$10.9K
FLG
139
Flagstar Bank National Association
FLG
$5.93B
$710K 0.06%
27,500
-267
-1% -$7.15K
QQQ icon
140
Invesco QQQ Trust
QQQ
$453B
$674K 0.06%
2,533
-119
-4% -$32.9K
DAN icon
141
Dana Inc
DAN
$2.9B
$661K 0.06%
43,700
-2,500
-5% -$38.8K
AFT
142
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$653K 0.06%
52,900
+2,200
+4% +$27.5K
PG icon
143
Procter & Gamble
PG
$336B
$652K 0.06%
4,300
-799
-16% -$112K
XBI icon
144
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$651K 0.05%
7,844
-525
-6% -$42.5K
EFV icon
145
iShares MSCI EAFE Value ETF
EFV
$28.8B
$638K 0.05%
13,896
+2,355
+20% +$102K
MS icon
146
Morgan Stanley
MS
$331B
$637K 0.05%
7,495
-17
-0.2% -$1.45K
FEIM icon
147
Frequency Electronics
FEIM
$635M
$636K 0.05%
90,181
AFL icon
148
Aflac
AFL
$64.9B
$634K 0.05%
8,818
CHTR icon
149
Charter Communications
CHTR
$17.3B
$633K 0.05%
1,868
-830
-31% -$292K
YUMC icon
150
Yum China
YUMC
$16.5B
$627K 0.05%
11,468
-700
-6% -$35.6K

Similar funds

Shufro Rose & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Shufro Rose & Co held 360 positions worth $1.19B, up 18% from $1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Shufro Rose & Co deployed $103M of net new capital in Q4 2022, opening 23 new positions and adding to 72 existing holdings. Its largest new stake was iShares iBonds Dec 2023 Term Treasury ETF: 2,784,203 shares worth $68.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBonds Dec 2026 Term Corporate ETF, an estimated $63.5M trimmed.

  • Shufro Rose & Co's largest Q4 2022 buy was iShares iBonds Dec 2023 Term Treasury ETF: 2,784,203 shares worth $68.8M.
  • Shufro Rose & Co added most to Invesco BulletShares 2026 Corporate Bond ETF in Q4 2022, an estimated $63.7M increase.
  • Shufro Rose & Co's biggest Q4 2022 reduction was iShares iBonds Dec 2026 Term Corporate ETF, cutting an estimated $63.5M.
  • Shufro Rose & Co fully exited Goldman Sachs Equal Weight US Large Cap Equity ETF in Q4 2022, selling an estimated $9.02M.
  • Shufro Rose & Co's ten largest holdings make up 36% of its $1.19B portfolio in Q4 2022.
  • Shufro Rose & Co opened 23 new positions and closed 16 in Q4 2022.
  • Shufro Rose & Co's portfolio value rose 18% quarter-over-quarter to $1.19B.

Based on Shufro Rose & Co's 13F filing for Q4 2022, filed 25 Jan 2023.